Soluble interleukin-2 receptor level in serum of children with insulin-dependent diabetes mellitus compared with that in diseases with activated immune system

Robb, 1981, T cell growth factor receptors: quantitation, specificity and biological relevance, J. Exp. Med., 154, 1455, 10.1084/jem.154.5.1455 Greene, 1986, The human interleukin 2 receptor, Ann. Rev. Immunol., 4, 69, 10.1146/annurev.iy.04.040186.000441 Cantrell, 1984, The interleukin-2 T cell system; a new cell growth model, Science, 224, 1312, 10.1126/science.6427923 Rubin, 1985, Soluble interleukin-2 receptors are released from activated human lymphoid cells in vitro, J. Immunol., 135, 3172, 10.4049/jimmunol.135.5.3172 Airo, 1992, Evaluation of serum levels of soluble interleukin-2 receptor as an indicator of disease activity in systemic lupus erythematosus, Clin. Rheumatol., 11, 97, 10.1007/BF02207093 Rubin, 1990, The soluble interleukin-2 receptor in rheumatic disease, Arthritis Rheum., 33, 1145, 10.1002/art.1780330814 Matsuura, 1992, Soluble interleukin-2 and CD8 and CD4 receptors in inflammatory bowel disease, Gastroenterology, 102, 2006, 10.1016/0016-5085(92)90326-T Mandereoli, 1992, Lymphocyte release of soluble IL-2 receptors in patients with minimal change nephropathy, Clin. Nephrol., 37, 177 McCuish, 1974, Antibodies to pancreatic islet cells in insulin-dependent diabetic with coexistence autoimmune disease, Lancet, II, 1529, 10.1016/S0140-6736(74)90281-5 Riley, 1988, The predictability of insulin-dependent diabetes mellitus, Adv. Pediatr., 35, 167 Zier, 1984, Decreased synthesis of interleukin-2 (IL-2) in insulin-dependent diabetes mellitus, Diabetes, 33, 552, 10.2337/diabetes.33.6.552 1979, Classification and diagnosis of diabetes mellitus and other categories of glucose intollerance, Diabetes, 28, 1039, 10.2337/diab.28.12.1039 Chase, 1987, Diagnosis of pre-type I diabetes, J. Pediatr., 111, 807, 10.1016/S0022-3476(87)80192-0 Leonard, 1982, Monoclonal antibody that appears to recognize the receptor in human T cell growth factor; partial characterization of the receptor, Nature, 300, 267, 10.1038/300267a0 Cantrell, 1983, Transient expression of interleukin-2 receptors - consequence for T cell growth factor, J. Exp. Med., 153, 1895, 10.1084/jem.158.6.1895 Hemler, 1984, Antigenic stimulation regulates the level of expression of interleukin-2 receptor on human T cell, 81, 2172 Kaye, 1986, Acquired defect in interleukin-2 production in patients with type 1 diabetes mellitus, New Engl. J. Med., 315, 920, 10.1056/NEJM198610093151502 Obara, 1991, Cell free IL-2R test kit for determination of soluble IL-2 receptor in human serum, Rinsho Kensa, 35, 539 Giordano, 1988, Dissociated production of interleukin-2 and immune gamma-interferon by phytohemagglitinin stimulated peripheral mononuclear cells in type 1 (insulin-dependent) diabetes, J. Clin. Lab. Immunol., 27, 73 Giordano, 1988, Increased soluble interleukin-2 receptor levels in the sera of type 1 diabetic patient, Diabetes Res., 8, 135 Roncarolo, 1988, Interleukin-2 production and interleukin-2 receptor expression in children with newly diagnosed diabetes, Clin. Immunol. Immunopathol., 49, 53, 10.1016/0090-1229(88)90094-3 Rubin, 1986, The released interleukin-2 receptor binds interleukin 2 efficiently, J. Immunol., 137, 3841, 10.4049/jimmunol.137.12.3841 Keller, 1989, Developmental regulation of serum interleukin-2 receptor concentrations: Attenuation of the childhood peak in patients at risk for developing or having recently developed type 1 diabetes mellitus, J. Pediatr., 114, 816, 10.1016/S0022-3476(89)80146-5 Vialette, 1991, The soluble receptor of interleukin 2 is not a serum marker of the autoimmune activity in type 1 diabetes mellitus, Autoimmunity, 11, 53, 10.3109/08916939108994708 Robb, 1984, Interleukin-2: the molecule and its function, Immunol. Today, 5, 203, 10.1016/0167-5699(84)90224-X